Home
NICE Guidance
Published Guidance

The clinical effectiveness and cost effectiveness of infliximab for Crohn's disease

Technology appraisal guidance [TA40] Published: 26 April 2002

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 187.